Cantel Medical Corp/ US1380981084 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 3.4 bill.USD | 0.13% | 251.16 |
Assets
|
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 74.6040 | 88.3380 | 111.4170 | 185.2420 | 225.2220 | ||||||
Intangible Assets | 111.7190 | 124.5120 | 137.3610 | 141.5130 | 480.0320 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 471.7900 | 529.0020 | 625.4650 | 718.5700 | - | ||||||
Inventories | 91.4860 | 98.7240 | 107.5920 | 138.2340 | 167.9600 | ||||||
Accounts Receivable | 93.3320 | 110.6560 | 118.6420 | 146.9100 | 148.4190 | ||||||
Cash and Cash Equivalents | 28.3670 | 36.5840 | 94.0970 | 44.5350 | 277.8710 | ||||||
Current Assets | 222.7420 | 257.3710 | 338.2430 | 351.7960 | 646.6260 | ||||||
Total Assets | 694.5320 | 786.3730 | 963.7080 | 1,070.3660 | 2,071.7540 |
Liabilities
|
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 26.2630 | 27.4690 | 34.2580 | 39.4500 | 42.0080 | ||||||
Long-term debt | 116 | 126 | 187.3020 | 220.8510 | 1,051.6690 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 27.7000 | 27.9000 | 30.4000 | 32.1000 | 53.9000 | ||||||
Liabilities | 240.1620 | 262.4410 | 354.8410 | 408.8290 | 1,342.1550 | ||||||
Share Capital | 4.6080 | 4.6190 | 4.6240 | 4.6360 | 4.6810 | ||||||
Total Equity | 454.3700 | 523.9320 | 608.8670 | 661.5370 | 729.5990 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 694.5320 | 786.3730 | 963.7080 | 1,070.3660 | 2,071.7540 |
Income Statement
|
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 664.7550 | 770.1570 | 871.9220 | 918.1550 | 1,016.0480 | ||||||
Depreciation (total) | 25.0840 | 33.4520 | 34.8300 | 42.3590 | 63.4020 | ||||||
Operating Result | 97.2510 | 110.4100 | 121.6640 | 83.5190 | 48.3070 | ||||||
Interest Income | -3.3200 | -4.3030 | -5.2890 | -9.5050 | -41.3550 | ||||||
Income Before Taxes | 93.9310 | 106.2330 | 117.5130 | 75.3190 | 6.9520 | ||||||
Income Taxes | 33.9780 | 34.8550 | 26.4720 | 20.2770 | -6.7560 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 59.9530 | 71.3780 | 91.0410 | 55.0420 | 13.7080 |
Per Share
Cash Flow
|
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 80.2680 | 108.1930 | 125.9120 | 66.9310 | 136.8570 | ||||||
Cash Flow from Investing Activities | -112.9820 | -97.0620 | -125.1860 | -133.0290 | -752.8590 | ||||||
Cash Flow from Financing | 29.9420 | -2.7510 | 57.1370 | 14.7020 | 852.6700 | ||||||
Decrease / Increase in Cash | -3.3530 | 8.2170 | 57.5130 | -49.5620 | 233.3360 | ||||||
Employees | 2,000 | 2,337 | 2,693 | 2,775 | 3,669 |